Internal Medicine, Gastroenterology · Melbourne, FL
NPI
1700983863
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
25 Silver Palm Ave, Suite B
Melbourne, FL, 32901
Phone (321) 725-4150
Groups this clinician bills Medicare through
Medicare paid, 2024
$129K
5,412 services
Medicare patients, 2024
450
Average age 73
Drug cost, 2024
$511K
1,407 prescriptions
Company payments, 2025
$1,509
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shireen F Gadallah was code 99214 (office e&m - established), 596 times for 327 patients. In total Shireen F Gadallah billed 5,412 services in 31 codes, and Medicare paid $129K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 596 | 327 | $88.49 | $53K |
| 99204 Office E&M - New | Office | 121 | 121 | $109.35 | $13K |
| 43239 Upper GI Endoscopy | Facility | 113 | 111 | $70.16 | $7,928 |
| 45380 Lower GI Endoscopy - Other | Facility | 69 | 69 | $119.81 | $8,267 |
| 45385 Colonoscopy - Lesion Removal | Facility | 46 | 46 | $205.15 | $9,437 |
| 76981 Ultrasound - Nonspecific | Office | 29 | 28 | $73.40 | $2,129 |
| 99213 Office E&M - Established | Office | 26 | 25 | $62.04 | $1,613 |
| 99215 Office E&M - Established | Office | 23 | 19 | $118.11 | $2,717 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 20 | 20 | $180.13 | $3,603 |
| 99223 Hospital E&M - Initial | Facility | 14 | 13 | $125.89 | $1,763 |
By year: 2022 $118K for 3,706 services; 2023 $182K for 7,557 services; 2024 $129K for 5,412 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shireen F Gadallah prescribed most often to Medicare patients was Pantoprazole Sodium, with 288 prescriptions and refills. In total Shireen F Gadallah wrote 1,407 Medicare prescriptions that cost $511K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 288 | 813 | 103 | $4,296 |
| Omeprazole Generic | 108 | 288 | 38 | $1,685 |
| Metoclopramide Hcl Generic | 85 | 138 | 24 | $940 |
| Famotidine Generic | 77 | 113 | Under 11 | $824 |
| Mounjaro Tirzepatide | 56 | 58 | Under 11 | $58K |
| Ondansetron Odt Ondansetron | 44 | 60 | 16 | $2,788 |
| Zenpep Lipase/Protease/Amylase | 40 | 61 | Under 11 | $100K |
| Linzess Linaclotide | 35 | 53 | Under 11 | $28K |
| Metronidazole Generic | 35 | 35 | 22 | $318 |
| Esomeprazole Magnesium Generic | 32 | 70 | Under 11 | $1,049 |
| Creon Lipase/Protease/Amylase | 28 | 39 | Under 11 | $33K |
| Lorazepam Generic | 28 | 32 | Under 11 | $372 |
| Voquezna Vonoprazan Fumarate | 26 | 42 | Under 11 | $27K |
| Dexlansoprazole Dr Dexlansoprazole | 26 | 60 | Under 11 | $9,278 |
| Ciprofloxacin Hcl Generic | 23 | 23 | 12 | $111 |
Brand drugs: 276 claims; generic drugs: 1,131 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shireen F Gadallah $1,509 ($1,509 in general payments such as food, travel and fees) from 16 companies. The largest payer was Pfizer Inc. with $280.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 13 | $280 |
| Novo Nordisk Inc NVO | 8 | $235 |
| Abbvie Inc. ABBV | 15 | $215 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $194 |
| Gilead Sciences, Inc. GILD | 2 | $142 |
| Boston Scientific Corporation BSX | 2 | $81.31 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $79.98 |
| Genzyme Corporation SNY | 3 | $72.07 |
| Intercept Pharmaceuticals, Inc. | 3 | $58.44 |
| Evoke Pharma, Inc. EVOK | 2 | $31.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.